Canoderm (Urea 5%): Uses, Dosage & Side Effects

A moisturizing emollient cream containing 5% urea for dry skin treatment and prevention of atopic eczema relapse

OTC Emollient Cream
Active Ingredient
Urea (carbamide) 5%
Available Forms
Cream
Strength
50 mg/g (5%)
Brand Name
Canoderm

Canoderm is a white emollient cream containing 5% urea (carbamide), a naturally occurring substance in the skin that plays a vital role in maintaining hydration. Urea has water-binding (humectant) properties that help normalize dry skin by drawing moisture into the outermost layer of the epidermis (stratum corneum). Canoderm is used for moisture-retaining treatment of dry skin of various origins – including xerosis, ichthyosis, and age-related dryness – and for preventing relapse of atopic eczema (atopic dermatitis). It is available over the counter in multiple sizes, from tubes to pump dispensers, and is suitable for use during pregnancy and breastfeeding. As a topical emollient, Canoderm has an excellent safety profile with no known systemic effects or drug interactions.

Quick Facts: Canoderm

Active Ingredient
Urea (Carbamide)
Drug Class
Emollient / Moisturizer
Concentration
5%
Common Uses
Dry Skin & Eczema
Available Forms
Cream
Prescription Status
OTC

Key Takeaways

  • Canoderm contains 5% urea, a natural skin moisturizer: Urea is a key component of the skin’s own natural moisturizing factor (NMF) and works by drawing water into the stratum corneum, restoring hydration and softening dry, rough skin.
  • It is clinically proven to prevent atopic eczema relapse: Regular emollient use with urea-based creams like Canoderm reduces the frequency and severity of eczema flare-ups, as recommended by international dermatology guidelines (BAD, AAD, NICE).
  • Safe during pregnancy and breastfeeding: Canoderm has no systemic absorption concerns and can be used throughout pregnancy and while nursing without risk to the mother or child.
  • Apply liberally and frequently for best results: For optimal effect, apply several times daily and always after contact with water. The cream should be applied generously until the skin has absorbed as much as possible without feeling greasy.
  • Mild, transient stinging may occur: A brief stinging or warmth sensation is a common side effect, particularly on the face and on areas of severely compromised skin. This is temporary and diminishes with continued use.

What Is Canoderm and What Is It Used For?

Canoderm is a white emollient cream containing 5% urea (carbamide) as its active ingredient. It is used for moisture-retaining treatment of dry skin of various origins and for preventing relapse of atopic eczema. Urea has water-binding properties that help normalize the skin’s hydration levels.

The skin’s outermost layer, the stratum corneum, acts as a critical barrier between the body and the external environment. This barrier function depends on a delicate balance of lipids, proteins, and natural moisturizing factors (NMF). Urea is one of the most important components of NMF, typically comprising 7–10% of the dry weight of the stratum corneum. When urea levels are depleted – due to environmental factors, genetic conditions, aging, or disease – the skin loses its ability to retain water effectively, resulting in dryness, flaking, roughness, and itching.

Canoderm works by supplementing the skin’s natural urea content. At a 5% concentration, topically applied urea acts primarily as a humectant, meaning it attracts and binds water molecules within the stratum corneum. This increased water content improves skin flexibility, softness, and appearance. Research published in the British Journal of Dermatology and the Journal of the European Academy of Dermatology and Venereology has consistently demonstrated that regular application of urea-based emollients significantly improves objective skin hydration parameters, reduces transepidermal water loss (TEWL), and improves subjective measures of skin comfort.

Beyond its humectant properties, urea at concentrations of 5% and above also exhibits mild keratolytic (skin-softening) activity. It gently promotes the desquamation of dead skin cells from the surface of the stratum corneum, which helps smooth rough, scaly patches characteristic of conditions like xerosis and ichthyosis. This dual mechanism – hydration enhancement combined with gentle exfoliation – makes urea-based creams particularly effective for the management of chronically dry skin.

Conditions Treated with Canoderm

Canoderm is indicated for a range of dry skin conditions. While many patients use it as a general-purpose moisturizer, it is particularly beneficial for the following:

  • Xerosis (dry skin): The most common indication, affecting an estimated 29–85% of older adults. Urea-based emollients are considered first-line treatment for xerosis by international dermatology guidelines.
  • Atopic eczema (atopic dermatitis) – maintenance therapy: Emollients form the cornerstone of long-term eczema management. Canoderm is specifically indicated for preventing eczema relapse by maintaining the skin barrier between flare-ups.
  • Ichthyosis: Inherited skin conditions characterized by dry, scaly skin. Urea creams help soften the thickened, fish-like scales and improve skin texture.
  • Contact dermatitis (preventive care): Occupational and irritant contact dermatitis often improves with regular emollient use as part of a skin protection regimen.
  • Diabetic dry skin: Diabetic xerosis affects up to 75% of people with diabetes. Urea-based emollients are specifically recommended by diabetic foot care guidelines for managing dry skin on the feet and lower legs.
  • Psoriasis (adjunctive care): While not a primary treatment, emollients like Canoderm can complement topical therapies by reducing scaling and improving skin comfort.
The role of emollients in eczema management

International guidelines from the British Association of Dermatologists (BAD), the American Academy of Dermatology (AAD), and the National Institute for Health and Care Excellence (NICE) all recommend liberal and frequent use of emollients as the foundation of atopic eczema treatment. Studies show that consistent emollient therapy reduces the need for topical corticosteroids by up to 50%, decreases eczema flare frequency, and improves overall quality of life. For atopic eczema prevention with Canoderm, application should be at least twice daily and after every contact with water.

How Urea Works in the Skin

Urea (carbamide, chemical formula CO(NH₂)₂) is a small, water-soluble organic compound naturally produced by the body as a metabolic waste product. In the skin, however, it plays an active and essential role. It is produced during the breakdown of filaggrin, a structural protein in the epidermis, and constitutes a significant portion of the skin’s natural moisturizing factor.

When applied topically at 5%, urea penetrates the stratum corneum within minutes and integrates into the skin’s natural moisturizing system. It increases the water-holding capacity of the skin through hydrogen bonding with water molecules, effectively acting as a biological sponge. The humectant effect begins shortly after application and persists for several hours. With regular use, urea helps normalize epidermal turnover and restore the compromised skin barrier, leading to sustained improvement in skin condition rather than merely temporary relief.

At higher concentrations (10–40%), urea has stronger keratolytic properties and can be used to treat more severe hyperkeratotic conditions such as plantar calluses, severe ichthyosis, and psoriatic plaques. At 5%, as in Canoderm, the primary effect is moisturizing with mild keratolysis, making it well-suited for daily use on large body surface areas without significant irritation.

What Should You Know Before Using Canoderm?

Canoderm has very few contraindications due to its topical, non-systemic nature. Do not use it if you are allergic to urea (carbamide) or any of the other ingredients. Avoid applying the cream to eyes, nose, ears, open wounds, or mucous membranes. Canoderm is safe during pregnancy and breastfeeding and does not affect the ability to drive or operate machinery.

Contraindications

Canoderm should not be used if you have a known allergy (hypersensitivity) to urea (carbamide) or any of the other ingredients in the cream. True allergy to urea itself is extremely rare since it is a natural substance produced by the body. However, the cream contains several excipients that may cause reactions in sensitive individuals:

  • Ethyl parahydroxybenzoate (E 214) and methyl parahydroxybenzoate (E 218): These preservatives (parabens) can cause allergic reactions in some people. Reactions may be delayed (type IV hypersensitivity), meaning they can appear 24–72 hours after contact.
  • Cetostearyl alcohol: A fatty alcohol used as an emulsifier that can cause local skin reactions such as contact dermatitis in sensitized individuals.
  • Propylene glycol (50 mg per gram): A solvent that may cause skin irritation in some people, particularly at higher concentrations or with prolonged use on damaged skin.

If you have a documented allergy to any of these ingredients from previous patch testing, consult your pharmacist or dermatologist for an alternative emollient formulation. Many urea-based creams are available with different excipient profiles.

Warnings and Precautions

While Canoderm is generally very well tolerated, observe the following precautions for safe use:

  • Avoid contact with sensitive areas: Do not apply the cream in or around the eyes, nostrils, ear canals, open wounds, or on mucous membranes. If accidental contact with the eyes occurs, rinse thoroughly with water.
  • Expect initial stinging on very dry or damaged skin: When first applied to severely dry, cracked, or inflamed skin, urea-based creams commonly cause a brief stinging or warmth sensation. This is a recognized pharmacological effect, not an allergic reaction, and typically subsides within a few minutes. The sensation usually decreases with continued use as the skin barrier improves.
  • Facial skin is more sensitive: The face has thinner skin with higher nerve density, making it more susceptible to the stinging effect. Consider testing on a small area first if you have not used urea-based products on your face before.
  • Do not use on actively infected skin: If you have a bacterial, viral, or fungal skin infection, treat the infection first before applying emollients, as occluding the area can potentially worsen the infection.

Pregnancy and Breastfeeding

Canoderm can be safely used during pregnancy and breastfeeding. Urea is a naturally occurring substance in the body, and topical application at 5% concentration does not result in clinically significant systemic absorption. There are no reported adverse effects on fetal development, pregnancy outcomes, or nursing infants. The European Medicines Agency (EMA) classifies topical urea preparations as safe for use during pregnancy and lactation.

Breastfeeding mothers should avoid applying the cream directly on the nipples or areola before nursing, as the infant could ingest the cream during feeding. If the cream is applied to the breast area, it should be thoroughly washed off before breastfeeding.

Driving and Operating Machinery

Canoderm does not affect the ability to drive or operate machinery. It is applied topically, has no systemic absorption, and produces no central nervous system effects.

How Does Canoderm Interact with Other Products?

Canoderm has no known drug interactions because urea at 5% concentration does not undergo significant systemic absorption. However, when using other topical products on the same skin area, proper application timing is important to ensure each product works effectively.

Unlike many oral medications, topical emollients like Canoderm do not enter the bloodstream in meaningful quantities and therefore do not interact with other systemic medications. You can safely use Canoderm while taking any prescription or over-the-counter oral medications. However, there are practical considerations when combining Canoderm with other topical products applied to the same area of skin.

Combining with Topical Corticosteroids

Canoderm is frequently used alongside topical corticosteroids (such as hydrocortisone, betamethasone, or mometasone) in the management of atopic eczema and other inflammatory skin conditions. International guidelines recommend emollients as the foundation of eczema treatment, with corticosteroids reserved for active flare-ups. When using both:

  • Apply the emollient (Canoderm) first, then wait 15–30 minutes before applying the topical corticosteroid
  • Alternatively, apply them at different times of day (e.g., emollient in the morning, corticosteroid in the evening)
  • This separation ensures that the emollient does not dilute or spread the corticosteroid beyond the intended treatment area

Combining with Other Topical Treatments

Similar timing considerations apply when using Canoderm with other topical treatments:

Combining Canoderm with Other Topical Products
Product Type Recommendation Wait Time
Topical corticosteroids Apply Canoderm first, then corticosteroid 15–30 minutes
Topical calcineurin inhibitors (e.g., tacrolimus, pimecrolimus) Apply Canoderm first, then calcineurin inhibitor 15–30 minutes
Topical retinoids (e.g., tretinoin, adapalene) Apply at different times of day to reduce irritation Separate times
Sunscreen Apply Canoderm first, let absorb, then apply sunscreen 15–20 minutes
Topical antifungals Apply Canoderm after the antifungal has been absorbed 15–30 minutes

The key principle is to allow each product adequate time to absorb into the skin before applying the next one. Applying multiple topical products simultaneously can reduce the efficacy of active treatments or cause them to spread to unintended areas.

Urea and Skin Permeation

It is worth noting that urea at higher concentrations (10% and above) can act as a penetration enhancer, potentially increasing the absorption of other topically applied substances. However, at the 5% concentration found in Canoderm, this effect is minimal and clinically insignificant. There is no evidence that Canoderm meaningfully alters the absorption or efficacy of other topical medications when proper application intervals are observed.

What Is the Correct Dosage of Canoderm?

For dry skin treatment, apply Canoderm as needed, preferably several times daily and always after contact with water. For prevention of atopic eczema relapse, apply at least twice daily and after every contact with water. Apply enough cream for the skin to absorb without feeling greasy.

The dosage of Canoderm is not measured in milligrams like oral medications, but rather in the amount applied to the skin and the frequency of application. The goal is to maintain continuous hydration of the skin barrier, which requires regular, generous application. Dermatology guidelines emphasize that many patients under-use emollients, applying too little or too infrequently for optimal benefit.

Adults

Dry Skin of Various Origins

Apply Canoderm as needed, preferably several times daily. Always reapply after contact with water (bathing, showering, swimming, or hand washing). Massage gently into the skin until it has been absorbed as much as possible without leaving a greasy residue. There is no maximum number of daily applications – the cream can be used as often as the skin needs it.

Prevention of Atopic Eczema Relapse

Apply Canoderm at least twice daily and preferably after every contact with water. Consistent, long-term use is essential for maintaining the skin barrier and reducing flare-up frequency. Studies show that patients who apply emollients at least twice daily have significantly fewer eczema episodes than those who apply less frequently. For best results, continue regular application even when the skin appears healthy.

Children

Canoderm can be used in children, including infants, under the guidance of a healthcare provider. The same application principles apply as for adults: apply as needed for dry skin, or at least twice daily for eczema prevention. Children may be more sensitive to the stinging sensation, particularly on the face. If stinging is distressing, try warming the cream between the palms before application, which can reduce the sensation. For very young infants (under 3 months), consult a pediatrician or dermatologist before starting any new topical product.

Elderly

Canoderm is well-suited for elderly patients, who are disproportionately affected by xerosis. Age-related changes in skin physiology – including reduced sebaceous gland activity, decreased NMF levels, and impaired barrier function – make regular emollient use particularly important. No dose adjustment is required. Elderly patients may benefit from using larger pack sizes (pump dispensers) for ease of application, especially if manual dexterity is limited.

Application Tips

The effectiveness of emollient therapy depends largely on proper application technique. The following tips, based on dermatology best practices, help maximize the benefit of Canoderm:

  • Apply to slightly damp skin: Pat the skin partially dry after bathing (leaving some moisture) and then apply Canoderm immediately. This helps trap additional moisture in the skin.
  • Stroke in the direction of hair growth: Applying emollient in the direction of hair growth reduces the risk of folliculitis (inflamed hair follicles), a condition that can occur when creams are rubbed vigorously against the natural hair direction.
  • Use enough: A common guideline is the “fingertip unit” (FTU) system. One FTU (the amount squeezed from the tip of the tube to the first crease of the index finger) covers approximately 2 palm-sized areas of skin. Adults typically need 250–500 grams per week for full-body coverage.
  • Do not share pumps or tubs: For hygiene, use a clean spoon or spatula to scoop cream from large tubs to avoid contamination. Pump dispensers are more hygienic for repeated use.
  • Continue even when skin improves: Emollient therapy is a long-term commitment. Stopping when the skin looks better often leads to rapid return of dryness and increased risk of eczema flare-ups.
How much emollient is enough?

The British Association of Dermatologists (BAD) recommends that adults with widespread eczema use 250–500 grams of emollient per week, while children need proportionally less based on body surface area. Most patients significantly underuse their emollient. If your skin still feels tight or dry between applications, you likely need to apply more frequently or use a larger amount per application.

Missed Application

Unlike prescription medications, there is no concept of a “missed dose” with Canoderm. If you forget to apply the cream, simply apply it as soon as you remember. There is no need to apply extra to make up for a missed application. The key is to maintain as consistent a routine as possible for optimal skin hydration.

Overdose

Overdose with Canoderm is not a clinical concern. Urea is a natural body substance, and topical application at 5% does not produce systemic effects regardless of the amount applied. If the cream is accidentally ingested in small quantities, no adverse effects are expected. If large amounts are swallowed, contact a poison control center as a precaution, though significant toxicity is extremely unlikely.

What Are the Side Effects of Canoderm?

Canoderm is very well tolerated. The most common side effects are mild, transient stinging and a warmth sensation at the application site, occurring in more than 1 in 100 users. The face is particularly sensitive. Serious side effects are extremely rare.

As with all medications, Canoderm can cause side effects, although most people will not experience them. The side effect profile of Canoderm is very favorable compared to many other dermatological treatments, reflecting the fact that urea is a naturally occurring substance in the skin. Most reported side effects are local and transient, resolving without the need to discontinue treatment.

The following classification uses the standard pharmacovigilance frequency categories defined by the European Medicines Agency (EMA):

Common

Affects more than 1 in 100 users

  • Transient stinging or burning sensation at the application site
  • Temporary warmth or heat feeling on the skin
  • Mild skin redness (erythema) immediately after application

Uncommon

Affects 1 in 100 to 1 in 1,000 users

  • Itching (pruritus) at the application site
  • Skin dryness paradoxically worsening initially before improving
  • Mild skin peeling or flaking as dead skin is shed

Rare

Affects fewer than 1 in 1,000 users

  • Allergic contact dermatitis (typically due to excipients such as parabens or cetostearyl alcohol, not urea itself)
  • Localized eczematous reaction at the application site
  • Folliculitis (inflamed hair follicles, usually from incorrect application technique)

Understanding Stinging and Warmth

The most frequently reported side effect – transient stinging and warmth – deserves further explanation because it is often misinterpreted as an allergic reaction. Urea is a small molecule that can temporarily stimulate sensory nerve endings (nociceptors) in the skin, particularly when the skin barrier is compromised. This pharmacological effect is not a sign of allergy or intolerance.

The stinging typically begins within seconds to minutes of application and subsides within 5–15 minutes as the cream is absorbed. It is most pronounced during the first few applications and tends to diminish over days to weeks as the skin barrier improves with continued emollient use. Factors that increase stinging include:

  • Application to the face, which has thinner skin and higher nerve density
  • Application to active eczema flares or cracked, fissured skin
  • Application immediately after bathing in hot water
  • Cold ambient temperature (cold skin may be more sensitive)

Strategies to minimize stinging include applying the cream to slightly damp (not wet) skin at room temperature, warming the cream between the palms before application, and starting with small amounts on sensitive areas. If stinging is very uncomfortable, temporarily switching to a urea-free emollient for the most sensitive areas while using Canoderm on the rest of the body is a reasonable approach.

When to Contact a Healthcare Provider

Consult your doctor, pharmacist, or dermatologist if:

  • Side effects become severe or do not improve after 1–2 weeks of continued use
  • You develop a rash, hives, or significant swelling at or beyond the application site (suggesting a possible allergic reaction to an excipient)
  • The treated skin condition worsens rather than improves
  • You notice signs of skin infection (increased redness, warmth, pus, or pain)

How Should You Store Canoderm?

Store Canoderm at or below 25°C (77°F). Keep out of the sight and reach of children. Do not use after the expiration date printed on the packaging.

Proper storage helps maintain the stability and effectiveness of Canoderm throughout its shelf life. The cream contains an emulsion system (oil-in-water) that can be affected by extreme temperatures.

  • Temperature: Store at or below 25°C (77°F). Do not freeze. Brief exposure to temperatures slightly above 25°C during normal transport is acceptable, but prolonged storage in hot environments (e.g., in a car during summer) should be avoided.
  • Light: Keep the cream in its original packaging. While not specifically light-sensitive, keeping the tube or pump in its box protects the product and helps track the expiration date.
  • Hygiene: Replace the cap or close the pump after each use. For tube formulations, avoid touching the tube opening to prevent contamination. For pump dispensers, the pump mechanism provides good protection against contamination.
  • Shelf life: Do not use Canoderm after the expiration date printed on the packaging. Once opened, the cream should be used within the timeframe recommended on the packaging (typically 6–12 months for tubes).
  • Children: Keep all medicines out of the sight and reach of children.

Do not dispose of unused cream via wastewater or household waste. Ask your pharmacist about the proper disposal of unused medicines to help protect the environment.

What Does Canoderm Contain?

The active substance is urea (carbamide) at 50 mg per gram (5%). The cream also contains a range of excipients that form the emulsion base, including medium-chain triglycerides, polysorbate 60, cetostearyl alcohol, propylene glycol, and parabens as preservatives.

Active Ingredient

Urea (carbamide): 50 mg per gram of cream (5% w/w). Urea is the sole active ingredient and provides the moisturizing and mild keratolytic effects. It is a naturally occurring metabolic product found in the skin, blood, and urine.

Excipients (Inactive Ingredients)

The following excipients form the cream base and provide the product’s texture, stability, and preservative properties:

Canoderm Excipients (Inactive Ingredients)
Ingredient Function Notes
Medium-chain triglycerides Emollient oil phase Provides smooth texture and occlusive properties
Polysorbate 60 Emulsifier Helps oil and water phases mix
Cetostearyl alcohol Emulsifier / thickener May cause contact dermatitis in sensitive individuals
Hydrogenated rapeseed oil Emollient oil phase Plant-derived lipid
Propylene glycol (50 mg/g) Solvent / humectant May cause skin irritation in some individuals
Carbomer Thickening agent Provides cream viscosity
Dimethicone Skin protectant Silicone-based emollient, creates a protective barrier
Hard paraffin Occlusive agent Helps prevent transepidermal water loss
Glycerol polymethacrylate Film-forming agent Helps cream adhere to skin
Ethyl parahydroxybenzoate (E 214) Preservative (paraben) May cause allergic reactions (possibly delayed)
Methyl parahydroxybenzoate (E 218) Preservative (paraben) May cause allergic reactions (possibly delayed)
Sodium lactate solution pH buffer / humectant Also a component of natural moisturizing factor
Lactic acid pH adjuster Helps maintain optimal skin-compatible pH
Glyceryl stearate Emulsifier Stabilizes the oil-water emulsion
Polyoxyethylene stearate Emulsifier Additional emulsion stabilizer
Purified water Vehicle / solvent Main component of the aqueous phase

Packaging Sizes

Canoderm is available in several packaging options to suit different usage patterns:

  • 30 g tube (polyethylene, screw cap) – convenient travel size
  • 100 g tube (polyethylene, snap cap) – standard size for daily use
  • 210 g tube (polyethylene, snap cap) – family or extended-use size
  • 380 g pump dispenser (polypropylene) – hygienic, easy-to-use for daily routine
  • 500 g pump dispenser (polypropylene) – large economy size
  • 500 g refill container (polypropylene) – eco-friendly refill for the pump dispenser
  • 600 g dual pack (500 g pump + 100 g tube) – home and travel combination

Not all pack sizes may be available in all markets. The cream is white in color and has a smooth, non-greasy texture when properly applied.

About parabens in Canoderm

Canoderm contains two parabens (ethyl and methyl parahydroxybenzoate) as preservatives. While parabens have been the subject of public concern, regulatory agencies including the EMA, FDA, and the European Commission’s Scientific Committee on Consumer Safety (SCCS) have concluded that parabens at the concentrations used in cosmetics and topical medicines are safe for human use. The concentrations in Canoderm are well within the limits established by these regulatory bodies. Individuals with a confirmed paraben allergy (diagnosed by patch testing) should use a paraben-free alternative.

Frequently Asked Questions

Canoderm is a 5% urea (carbamide) cream used as an emollient for moisture-retaining treatment of dry skin of various origins, including xerosis, ichthyosis, and age-related dryness. It is also specifically indicated for preventing relapse of atopic eczema (atopic dermatitis). Urea is a natural component of the skin’s moisturizing system that binds water and helps normalize dry skin.

Yes, Canoderm can be used on the face, but be aware that facial skin is thinner and more sensitive, making the transient stinging sensation more likely. Avoid the area around the eyes, nostrils, and mouth. Start with a small test area if you have not used urea-based products on your face before. If significant discomfort occurs, consider using a urea-free emollient for the face and Canoderm for the rest of the body.

Yes, Canoderm is safe to use during both pregnancy and breastfeeding. Urea is a naturally occurring substance in the body, and topical application at 5% does not result in clinically significant systemic absorption. There are no known risks to the fetus or nursing infant. However, breastfeeding mothers should avoid applying the cream on the nipples before nursing to prevent the baby from ingesting the product.

For general dry skin treatment, apply Canoderm as often as needed – ideally several times daily and always after contact with water. For atopic eczema relapse prevention, apply at least twice daily and preferably after every contact with water. There is no maximum number of daily applications. Apply enough that the skin absorbs the cream without feeling greasy.

The transient stinging sensation is a common and well-known pharmacological effect of urea on sensitive or compromised skin. Urea temporarily stimulates nerve endings in the skin, causing a brief burning or warmth feeling that typically subsides within 5–15 minutes. This is not an allergic reaction. The sensation usually decreases with continued use as the skin barrier improves. To minimize stinging, warm the cream between your palms before applying, apply to slightly damp skin, and avoid applying to actively inflamed or cracked areas.

Yes, Canoderm is commonly used alongside topical corticosteroids as part of eczema management. International guidelines recommend applying the emollient first, waiting 15–30 minutes, and then applying the corticosteroid. Alternatively, you can apply them at different times of day. This combination approach reduces the need for corticosteroids by maintaining the skin barrier and is endorsed by the British Association of Dermatologists, the American Academy of Dermatology, and NICE guidelines.

References

  1. 1 Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J. Urea: a comprehensive review of the clinical literature. Dermatology Online Journal. 2013;19(11):20392.
  2. 2 Lodén M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. American Journal of Clinical Dermatology. 2003;4(11):771–788.
  3. 3 National Institute for Health and Care Excellence (NICE). Atopic eczema in under 12s: diagnosis and management. Clinical guideline CG57. Updated 2023.
  4. 4 Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema. Journal of the European Academy of Dermatology and Venereology. 2022;36(9):1409–1431.
  5. 5 British Association of Dermatologists (BAD). Guidelines for the management of atopic eczema. British Journal of Dermatology. 2024.
  6. 6 Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis. Journal of the American Academy of Dermatology. 2014;71(1):116–132.
  7. 7 Guenther L, Lynde CW, Andriessen A, et al. Pathway to dry skin prevention and treatment. Journal of Cutaneous Medicine and Surgery. 2012;16(1):23–31.
  8. 8 Grether-Beck S, Felsner I, Brenden H, et al. Urea uptake enhances barrier function and antimicrobial defense in humans by regulating gene expression. Journal of Investigative Dermatology. 2012;132(6):1561–1572.
  9. 9 European Medicines Agency (EMA). Assessment report on topical urea-containing products. Committee on Herbal Medicinal Products (HMPC).
  10. 10 World Health Organization (WHO). WHO Model Formulary: Dermatological preparations. WHO Essential Medicines and Health Products. 2023.
  11. 11 Augustin M, Wilsmann-Theis D, Körber A, et al. Diagnosis and treatment of xerosis cutis – a position paper. Journal of the German Society of Dermatology. 2019;17(Suppl 7):3–33.
  12. 12 Van Zuuren EJ, Fedorowicz Z, Christensen R, et al. Emollients and moisturisers for eczema. Cochrane Database of Systematic Reviews. 2017;(2):CD012119.

About This Article

This article was written by the iMedic Medical Editorial Team, a group of licensed physicians, pharmacists, and medical writers with expertise in dermatology and clinical pharmacology. All content is based on peer-reviewed research, international clinical guidelines, and evidence-based medicine principles.

Medical Review

Reviewed by board-certified dermatologists and clinical pharmacists. Content verified against international guidelines from the British Association of Dermatologists (BAD), American Academy of Dermatology (AAD), NICE, and EMA.

Evidence Standards

Evidence Level 1A where available. All clinical claims are supported by systematic reviews, randomized controlled trials, or authoritative clinical guidelines following the GRADE framework.

Last medically reviewed:
First published:
Next review due: